NASDAQ:CRMD
CorMedix Inc.
CorMedix Inc.'s revenue grew 617.0% in fiscal 2025 to $311.7M while operating margin rose to 48.2%. Free cash flow was $172.8M, 55.4% of revenue, and the diluted share count rose 36.4%.Summary generated from CorMedix Inc.'s SEC filings. Latest annual report filed Mar 5, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$311.7M
Revenue growth+617.0%
Revenue, 5-yr CAGR+319.7%
Gross margin88.5%
Operating margin48.2%
Net margin52.3%
ROICn/a
Return on equity66.6%
Debt / equityn/a
Free cash flow$172.8M
FCF margin55.4%
Share count change+36.4%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | n/a | 43 | 312 |
| Operating income | −29 | −31 | −49 | −22 | 150 |
| Net income | −28 | −30 | −46 | −18 | 163 |
| Free cash flow | −23 | −25 | −39 | −51 | 173 |
Recent filings
- 4Insider transaction report
Sep 18, 2026 - 4Insider transaction report
Sep 1, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 8-KResults of operations and financial condition
Aug 13, 2026 - 8-KOther events
Aug 7, 2026 - 8-KOther events
Jul 2, 2026 - 8-KChange in auditor
Jul 1, 2026 - 8-KResults of a shareholder vote
Jun 24, 2026